Emergency hepatic metastasectomy for symptomatic control of metastatic VIPoma
DOI:
https://doi.org/10.18203/2349-2902.isj20250724Keywords:
Metastatectomy, VIPoma, Tumour debulking, Liver resectionAbstract
Vasoactive intestinal peptide-secreting tumours (VIPoma) are a rare subset of functioning pancreatic neuroendocrine tumours (pNET) which can lead to severe electrolyte derangement due to high volume secretory diarrhoea. Whilst surgery remains the mainstay in the management of non-metastatic disease, the role of debulking and surgical resection in metastatic disease is unclear, particularly with the proliferation of systemic therapy options. We outline a case of a male in his 80s presenting with severe metabolic derangements secondary to symptomatic metastatic VIPoma with hepatic metastases. He underwent a successful non-anatomical hepatic metastasectomy after initially failure of multiple lines of systemic medical therapy. The surgery was technically successful, and he recovered remarkably well in the post-operative period with almost immediate cessation of his symptoms.
Metrics
References
Abdullayeva L. VIPoma: Mechanisms, clinical presentation, diagnosis and treatment (Review). World Acad Sci J. 2019;1(5):229-35. DOI: https://doi.org/10.3892/wasj.2019.22
Iwasaki M, Akiba Y, Kaunitz JD. Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system. Res. 2019;8:78-9. DOI: https://doi.org/10.12688/f1000research.18039.1
Ito T, Igarashi H, Jensen RT. Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances. Best Pract Res Clin Gastroenterol. 2012;26(6):737-53. DOI: https://doi.org/10.1016/j.bpg.2012.12.003
Azizian A, König A, Ghadimi M. Treatment options of metastatic and nonmetastatic VIPoma: a review. Langenbecks Arch Surg. 2022;407(7):2629-36. DOI: https://doi.org/10.1007/s00423-022-02620-7
Williams JK, Schwarz JL, Keutgen XM. Surgery for metastatic pancreatic neuroendocrine tumors: a narrative review. Hepatobiliary Surg Nutr. 2023;12(1):69-83. DOI: https://doi.org/10.21037/hbsn-22-238
Dréanic J, Lepère C, El Hajjam M, Gouya H, Rougier P, Coriat R. Emergency therapy for liver metastases from advanced VIPoma: surgery or transarterial chemoembolization. Ther Adv Med Oncol. 2016;8(5):383-7. DOI: https://doi.org/10.1177/1758834016656495
Ghaferi AA, Chojnacki KA, Long WD, Cameron JL, Yeo CJ. Pancreatic VIPomas: subject review and one institutional experience. J of Gastrointestinal Surg. 2008;12(2):382-93. DOI: https://doi.org/10.1007/s11605-007-0177-0
Pasricha G, Padhi P, Daboul N, Monga DK. Management of Well-differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEPNETs): A Review. Clin Ther. 2017;39(11):2146-57. DOI: https://doi.org/10.1016/j.clinthera.2017.10.010
Hofland J, Falconi M, Christ E, Castaño JP, Faggiano A, Lamarca A, et al. European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes. J Neuroendocrinol. 2023;35(8):13318. DOI: https://doi.org/10.1111/jne.13318
Cervantes A, Adam R, Roselló S, Arnold D, Normanno N, Taïeb J, et al. Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow. Annals of Oncol. 2023;34(1):10-32. DOI: https://doi.org/10.1016/j.annonc.2022.10.003
Frilling A, Modlin IM, Kidd M, Russell C, Breitenstein S, Salem R, et al. Recommendations for management of patients with neuroendocrine liver metastases. Lancet Oncol. 2014;15(1):8-21. DOI: https://doi.org/10.1016/S1470-2045(13)70362-0
Partelli S, Bartsch DK, Capdevila J, Chen J, Knigge U, Niederle B, et al. ENETS consensus guidelines for standard of care in neuroendocrine tumours: surgery for small intestinal and pancreatic neuroendocrine tumours. Neuroendocrinol. 2017;105(3):255-65. DOI: https://doi.org/10.1159/000464292
Angelousi A, Koffas A, Grozinsky-Glasberg S, Gertner J, Kassi E, Alexandraki K, et al. Diagnostic and Management Challenges in Vasoactive Intestinal Peptide Secreting Tumors: A Series of 15 Patients. Pancreas. 2019;48(7):934-42. DOI: https://doi.org/10.1097/MPA.0000000000001347
Brugel M, Walter T, Goichot B, Smith D, Lepage C, Do Cao C, et al. Efficacy of treatments for VIPoma: A GTE multicentric series. Pancreatol. 2021;21(8):1531-9. DOI: https://doi.org/10.1016/j.pan.2021.08.001
Azizian A, König A, Hartmann A, Schuppert F, Seif Amir Hosseini A, Kitz J, et al. Surgical treatment of metastatic VIPoma: a case report. Therap Adv Gastroenterol. 2021;14:17562848211051132. DOI: https://doi.org/10.1177/17562848211051132
